Biogen Pharmachem Industries Limited (BOM:531752)
India
· Delayed Price · Currency is INR 0.9500
-0.0100 (-1.04%)
At close: Jun 16, 2025
BOM:531752 Revenue
Biogen Pharmachem Industries had revenue of 13.52M INR in the quarter ending March 31, 2025, a decrease of -266.31%.
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
619.97M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |